https://www.taxtmi.com/news?id=20670 Information asymmetry and distributional practices constrain consumer choice and limit competition in pharmaceuticals and healthcare; the Commission recommends supply side interventions such as broader public procurement, regulated electronic drug trading, strict and consistent application of statutory quality controls to address branded generic premiums (including consideration of a one company one drug one brand one price policy), and harmonised regulatory processes to ensure uniform implementation and time bound approvals. en-us Wed, 24 Oct 2018 17:29:16 +0530 Wed, 24 Oct 2018 17:29:16 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=20670 Information asymmetry and distributional practices constrain consumer choice and limit competition in pharmaceuticals and healthcare; the Commission recommends supply side interventions such as broader public procurement, regulated electronic drug trading, strict and consistent application of statutory quality controls to address branded generic premiums (including consideration of a one company one drug one brand one price policy), and harmonised regulatory processes to ensure uniform implementation and time bound approvals. News - Wed, 24 Oct 2018 17:29:16 +0530 https://www.taxtmi.com/news?id=20670